🕵️ Brainstorm CELL Therapeutics Inc. ($BCLI)
SEC insider & ownership activity, last 12 months · CIK 1137883 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | May 15, 2025 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | May 15, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | May 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 25, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 31, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 31, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |